skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

IMHOF, Anna ; BRUNNER, Philippe ; MARINCEK, Nicolas ; BRIEL, Matthias ; SCHINDLER, Christian ; RASCH, Helmut ; MÄCKE, Helmut R ; ROCHLITZ, Christoph ; MÜLLER-BRAND, Jan ; WALTER, Martin A

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2416-2423 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

VILLARD, Linda ; ROMER, Anna ; BRIEL, Matthias ; WALTER, Martin A ; MARINCEK, Nicolas ; BRUNNER, Philippe ; KOLLER, Michael T ; SCHINDLER, Christian ; NG, Quinn KT ; MÄCKE, Helmut R ; MÜLLER-BRAND, Jan ; ROCHLITZ, Christoph

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1100-1106 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer
Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer

Buess, Martin ; Terracciano, Luigi ; Reuter, Jürgen ; Ballabeni, Pierluigi ; Boulay, Jean-Louis ; Laffer, Urban ; Metzger, Urs ; Herrmann, Richard ; Rochlitz, Christoph F.

Neoplasia (New York, N.Y.), 2004-05, Vol.6 (3), p.207-212 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)
1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10)

Pestalozzi, B.C ; Tausch, C ; Dedes, K.J ; Rochlitz, C ; Zimmermann, S ; Von Moos, R ; Winterhalder, R.C ; Ruhstaller, T ; Mueller, A ; Buser, K.S ; Borner, M.M ; Novak, U ; Uhlmann Nussbaum, C ; Seifert, B ; Bigler, M ; Bize, V ; Berardi Vilei, S ; Rageth, C ; Aebi, S.P

European journal of cancer (1990), 2015-09, Vol.51, p.S313-S313 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

Marincek, Nicolas ; Jörg, Ann-Catherine ; Brunner, Philippe ; Schindler, Christian ; Koller, Michael T ; Rochlitz, Christoph ; Müller-Brand, Jan ; Maecke, Helmut R ; Briel, Matthias ; Walter, Martin A

Journal of translational medicine, 2013-01, Vol.11 (1), p.17-17, Article 17 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
STRAP Is a Strong Predictive Marker of Adjuvant Chemotherapy Benefit in Colorectal Cancer
STRAP Is a Strong Predictive Marker of Adjuvant Chemotherapy Benefit in Colorectal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

STRAP Is a Strong Predictive Marker of Adjuvant Chemotherapy Benefit in Colorectal Cancer

Buess, Martin ; Terracciano, Luigi ; Reuter, Jurgen ; Ballabeni, Pierluigi ; Boulay, Jean-Louis ; Laffer, Urban ; Metzger, Urs ; Herrmann, Richard ; Rochlitz, Christoph

Neoplasia (New York, N.Y.), 2004-11, Vol.6 (6), p.813-820 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels

Rochlitz, Christoph ; Dreno, Brigitte ; Jantscheff, Peter ; Cavalli, Franco ; Squiban, Patrick ; Acres, Bruce ; Baudin, Martine ; Escudier, Bernard ; Heinzerling, Lucie ; Morant, Rudolf ; Herrmann, Richard ; Dietrich, Pierre-Yves ; Dummer, Reinhard

Cancer gene therapy, 2002-03, Vol.9 (3), p.289-295 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)
5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)
Material Type:
Artigo 		Adicionar ao Meu Espaço

5019 Pegylated liposomal doxorubicin and Bevacizumab as first-line therapy for locallyrecurrent or metastatic breast cancer – a multicenter, single-arm phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)

Rochlitz, C ; von Moos, R ; Mannhart-Harms, M ; Winterhalder, R ; Rauch, D ; Müller, A ; Zaman, K ; Lerch, S ; Mayer, M ; Zappa, F

European journal of cancer supplements, 2009, Vol.7 (2), p.266-266 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

TARTOUR, E ; MEHTALI, M ; HERRMANN, R ; POUILLART, P ; FRIDMAN, W. H ; DORVAL, T ; SASTRE-GARAU, X ; JOYEUX, I ; MATHIOT, C ; PLEAU, J. M ; SQUIBAN, P ; ROCHLITZ, C ; COURTNEY, M ; JANTSCHEFF, P

British Journal of Cancer, 2000-12, Vol.83 (11), p.1454-1461 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
569 A phase I and pharmacokinetic study of oral administration of SU5416 in patients with advanced solid tumors
569 A phase I and pharmacokinetic study of oral administration of SU5416 in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

569 A phase I and pharmacokinetic study of oral administration of SU5416 in patients with advanced solid tumors

Salzberg, M. ; Pless, M. ; Rochlitz, C. ; Scigalla, P. ; Herrmann, R.

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S172-S172 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2002  (2)
  2. 2002Até2003  (2)
  3. 2004Até2010  (4)
  4. 2011Até2013  (3)
  5. Após 2013  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.